Skip to content
Clinical Trials
Our Network
Our Story
Clinical Trials
Our Network
Our Story
OnCore Login
Clinical Trials
Current Trials
Publications
Our Network
Clinical Trial Working Groups
Sponsor-Investigators
Fostering an Environment of Mentorship
Member Sites
Partners in Research
About
Our Story
Our Team
Annual Reports
Services
Biorepository & Correlative Services
Rapid Accrual
Efficient Timelines for Activation
Regulatory Compliance
Accurate & Relevant Data
News & Events
HCRN Calendar
Oncology Meetings
Make a Difference
Donate Now
Fundraising Events
Advocacy Organizations
Honor Your Hero
Careers
Contact
OnCore Login
network member
Rhode Island Hospital
Providence, Rhode Island
About Network Member
Website:
https://www.lifespan.org/centers-services/research-and-clinical-trials
https://www.lifespan.org/centers-services/research-and-clinical-trials
Currently Enrolling
HCRN-AML20-472
TAGALONG Trial: Phase II Study of TAGraxofusp and Azacitidine With or Without Venetoclax in Newly Diagnosed Secondary AML after Previous Exposure to HypOmethylatiNG Agents
Cancer areas:
Leukemia
AdventHealth Orlando
Penn Medicine Abramson Cancer Center
Rhode Island Hospital
Roswell Park Cancer Institute
Sylvester Comprehensive Cancer Center at the University of Miami
University of North Carolina Lineberger Comprehensive Cancer Center
Wake Forest Baptist Medical Center Comprehensive Cancer Center
Learn More
See clinicaltrials.gov
Current Trials
Our Network
Our Story
X
